stocktools
Dilution profile // every instrument, one screen, from SEC filings

PALISADE BIO, INC. (PALI)

CIK 1357459 · all EDGAR filings →

Overall dilution risk
HIGHworst of 4 computed signals (offering ability)
= the worst band among the computed sub-ratings, no hidden weighting
Offering ability
HIGH$435M registered
= total registered offering amount from the fee exhibits of live registrations (bands: $1M / $20M)
registered capacity, not remaining: amounts already taken down are not subtracted yet
Overhead supply
MEDIUMwarrants = 30% of O/S
= warrant shares outstanding divided by current shares outstanding (bands: 20% / 50%)
warrants only; converts, ATMs and equity lines are not in free structured data, so the true overhead is AT LEAST this
Historical dilution
HIGH+2442% O/S in 3y
= share count now vs 3 years ago (bands: 30% / 100%); a reverse split pushes this negative
a reverse-split-sized cliff is in this window; read the chart
Cash need
LOW~138.5 months of runway
= cash vs trailing operating burn (bands: 6mo / 24mo; positive operating CF = low)
the company itself flagged going-concern doubt

Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.

Shares outstanding over time

2020-10-312026-08-06

Latest: 174.3M shares as of Aug 6, 2026 (10-Q). Share count fell from 77.1M to 4.5M between Nov 10, 2022 and Mar 15, 2023, a pattern consistent with a reverse split (roughly 1-for-17); simultaneous issuance can skew the raw ratio, so confirm in the filings. The red bar marks the cliff.

Cash runway

Going-concern warning

auditor flagged substantial doubt

The company itself flagged going-concern doubt in a filing.

Full breakdown: cash runway tool · source filing →

Warrants

Warrants outstanding: 51.7M underlying shares, as reported Jun 30, 2026 (10-Q).

Reported exercise price: $0.66 (aggregate figure as tagged; individual tranches vary).

Balance-sheet fair value of warrants: $4.7M as of Jun 30, 2025.

Down-round (price protection) accounting has been tagged in this filer’s XBRL: some instrument carries repricing protection. Which tranche requires reading the exhibits.

Rough fully diluted estimate: 225.9M = 174.3M O/S + 51.7M warrant shares. An estimate, not a filing figure: it ignores converts, options and RSUs, and the two inputs carry different as-of dates.

Convertible notes

No convertible-note facts tagged in the 10-Q filed Aug 10, 2026. If convertible notes exist, their terms live in exhibit prose for this filer and are not parsed; absence of a tag is not proof of absence. The exhibits are the ground truth.

Fully diluted build-up

Shares outstanding plus every potential-share instrument the filer tagged in XBRL, each at its own as-of date. An estimate assembled from filed figures, not a filing figure itself.

Shares outstanding174.3MAug 6, 2026
+ Warrants (aggregate, as tagged) (if exercised)51.7MJun 30, 2026
Fully diluted estimate225.9M+29.6% vs O/S

Still excluded, because the filer does not tag them in countable form: employee options and RSUs, any instrument living only in exhibit prose, and instruments above missing a share count. Inputs carry different as-of dates, shown per row. Each figure traces to the tranche and note tables above and their cited filings.

Registrations and offerings

Registered offering capacity on live registrations: $434.6Mfrom the structured fee exhibits; registered is not remaining, takedowns are not subtracted

S-3May 12, 2026$300.0M registeredfiling →
S-1Sep 29, 2025$126.4M registeredfiling →
S-3Aug 15, 2025$8.2M registeredfiling →

Last 12 months: 1 executed · 4 registered.

EFFECTIVEMay 21, 2026SEC declared a registration effective — selling can beginEFFECT →
REGISTEREDMay 12, 2026S-3 registration — capacity to sell shares, not a sale yetS-3 →
EXECUTEDOct 2, 2025Final prospectus — offering priced (typical for IPOs and marketed share deals)424B4 →
REGISTEREDOct 1, 2025S-1MEF registration — capacity to sell shares, not a sale yetS-1MEF →
EFFECTIVESep 30, 2025SEC declared a registration effective — selling can beginEFFECT →
REGISTEREDSep 29, 2025S-1 registration — capacity to sell shares, not a sale yetS-1 →
EFFECTIVEAug 28, 2025SEC declared a registration effective — selling can beginEFFECT →
REGISTEREDAug 15, 2025S-3 registration — capacity to sell shares, not a sale yetS-3 →
EXECUTEDJul 25, 2025Unregistered share sale disclosed (8-K item 3.02)8-K →
WITHDRAWNJun 12, 2025Registration withdrawnRW →
REGISTEREDMay 27, 2025S-1 registration — capacity to sell shares, not a sale yetS-1 →
UPDATEDec 17, 2024Prospectus update — often a resale registration, not necessarily new capital424B3 →

Full history and shelf status: offering checker · S-3 shelf checker

Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.

Keep going: float checker · offering calendar · short-squeeze screener · full PALI workspace